MONTREAL, CANADA--(Marketwire - Sept. 29, 2011) - (OTCBB:BISU)(PINK SHEETS:BISU) - Bio Solutions Corp. is pleased to announce the closing of the acquisition of Type2 Defense: A powder form diabetic nutritional supplement drink.
Type2 Defense proprietary blend was developed by Dr. Chandrasekhar Mallangi. Dr. Mallangi was previously the head of Nestle Nutritional product development for 25 years. "We are very pleased to surround ourselves with high caliber people as Dr. Mallangi. As a fellow scientist, I can appreciate the work and dedication that has brought us to this point," stated Gilles Chaumillon, President and CEO.
"As we know, pre and type2 diabetes is one of the top five diseases in the world. T2 is composed of high antioxidant ingredients that have a proven clinical effect on keeping glucose levels in humans at normal levels. This proprietary blend of proven ingredients is the essential ingredient in the T2 Defense formula." T2 Defense will be packaged in a 30-pack, easy to deliver powder form drink to be taken once a day. "T2 Defense is the first of its kind," stated Gilles Chaumillon, President and CEO.
"I am strictly concentrating on the build out of our company. We at Bio Solutions Corp are trying to build value for shareholders. We will be launching a massive Search Engine Operation (SEO) campaign in order to drive interest and online sales. We would like to generate as much interest as possible in the product and building an online presence (and a brand) is a key component. Based on my industry relationships and past successes, I believe once we have the public's interest, the rest should follow. SEO will play a vital role," stated Bill Gallagher, Executive Vice-President.
"Type2 Defense was developed as a system that helps reduce and control the onslaught of diabetes. With a sound product, social marketing on the web, and top diabetes nutritionalists on board, we believe we have all the ingredients to make this product a huge success with substantial revenues by year two," stated Bill Gallagher, Executive Vice-President.
For more information on Bio-Solutions Corp. and its products, please visit the company's website at www.bio-solutionscorp.com
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Bio-Solutions actual results to differ materially from those in the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements and disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments, except if we are requested by a governmental authority or applicable law.